But now we have firm data showing we should use (it) in most women with advanced ovarian cancer who have had successful surgery to remove the bulk of their tumor.

This is the longest survival reported to date for advanced ovarian cancer.

In our trial, women who received part of their chemotherapy via an IP route had a median survival time of 16 months longer than women who received only IV chemotherapy.

This is a significant improvement in survival for women with this disease, which is most often diagnosed at an advanced stage.

This may tip the scales for some of those women. We could have significantly fewer cases of breast cancer in this country.

Deaths from cervical cancer could drop even lower if more women routinely had a Pap test. Because cervical cancer produces no symptoms in the early stage, regular screening is extremely important.